Colombia declares emergency over yellow fever outbreak
The mosquito-borne virus, which typically causes fever, muscle pains, nausea and headaches, is endemic to multiple countries in South America, including Colombia, where the current outbreak has had a high mortality rate.
At least 34 people have died among 74 confirmed cases since the start of the year, Minister of Health Guillermo Jaramillo told state-run Radio Nacional de Colombia on Wednesday.
"It's a disease with a mortality rate of nearly 50% among those infected," he said while explaining the emergency decree.
The virus has also spread beyond the rural regions traditionally considered at risk for outbreaks, "making it a threat to more communities," he said.
The most severe situation is in the coffee-growing Tolima area, where the number of detected yellow fever cases rose from four in September 2024 to 22 by mid-April, according to Jaramillo.
"We are going to require the carrying of the vaccination card for people entering or leaving Colombia," he told the radio station.
Colombia's President Gustavo Petro announced an economic emergency on top of the health decree, and called on citizens to get vaccinated.
"People who have not been vaccinated should not go to high-risk areas during Easter: for now the coffee area," he wrote on Facebook on Wednesday.
Petro blamed climate change for further spreading the virus by bringing the disease-carrying Aedes aegypti mosquitoes to higher altitudes.
On Tuesday, the United States Centers for Disease Control and Prevention (CDC) upgraded its yellow fever alert for South America to level two of four, noting "an increased number of cases of yellow fever have been reported in parts of South America."
It advised travelers to consider getting vaccinated against yellow fever or receiving booster shots before visiting some areas of Bolivia, Colombia and Peru.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Filipino Times
6 days ago
- Filipino Times
WHO urges immediate action against global Chikungunya outbreak
The World Health Organization (WHO) warned of a possible global outbreak of chikungunya virus, citing early signs similar to a major epidemic that occurred two decades ago. Chikungunya is a mosquito-borne viral disease that causes fever and severe joint pain. While rarely fatal, the illness can be debilitating and pose serious public health risks when outbreaks occur on a large scale. Chikungunya is not a disease that is widely known, but it has been detected and transmitted in 119 countries globally, putting 5.6 billion people at risk,' said the WHO's Diana Rojas Alvarez. Rojas Alvarez recalled that from 2004 to 2005, a significant chikungunya outbreak started in the Indian Ocean and eventually spread worldwide, affecting nearly half a million people. A similar pattern is emerging this year, with major outbreaks reported in Reunion, Mayotte, and Mauritius. WHO estimates that one-third of Reunion's population may already have been infected. The virus is now spreading to other areas in the region, including Madagascar, Somalia, and Kenya, with epidemic transmission also occurring in parts of South Asia. Imported cases linked to the Indian Ocean outbreak have been recorded in Europe, with local transmission in France and suspected cases in Italy. 'We are raising the alarm early so countries can prepare early, detect and strengthen all the capacities to avoid going through very large outbreaks,' said Rojas Alvarez. Although chikungunya's case fatality rate is less than one percent, large-scale outbreaks could lead to thousands of deaths and overwhelm health systems, she added. Chikungunya is transmitted by infected female Aedes mosquitoes, particularly Aedes aegypti and Aedes albopictus, also known as tiger mosquitoes. The latter species is expanding its range due to warming temperatures, making previously unaffected regions vulnerable. WHO urged the public to take precautionary measures, such as using mosquito repellents and eliminating stagnant water where mosquitoes breed.
Gulf Today
21-07-2025
- Gulf Today
Ryanair's profit more than doubled in April
Ryanair's net profit more than doubled in its April-June quarter on higher-than-expected last-minute fares and the timing of the Easter holidays, while bookings for rest of the summer are 'robust', Europe's largest low-cost carrier said on Monday. The Irish airline, Europe's largest by passenger numbers, said it was not seeing a negative trend of later-than-normal bookings reported by some rivals. 'Across the piece, bookings are good,' Chief Financial Officer Neil Sorahan said, describing consumer confidence as 'very strong.' Shares in the airline were up 6.5 per cent at 24.58 euros at 0725 GMT, just below the all-time high of 24.98 recorded on July 8. Ryanair reported a net profit of 820 million euros ($953 million) for its first quarter, which ended on June 30, up from 360 million euros in the same period last year when Easter was in March - and up from 663 million in the same period of 2023, the last time Easter was in April. A Ryanair poll of analysts had expected 716 million euros. Average fares rose 21% in the quarter, more than recovering the 15% fall recorded in the period last year. In the July-September quarter, when European airlines make most of their profit, Ryanair expects to recover 'almost all' of the 7 per cent fare decline seen last year, when it was hit by weak consumer sentiment and a dispute with some online travel agents. In June, Ryanair forecast that 'some of' the 7 per cent would be recovered. Asked about recent commentary from British low-cost rivals EasyJet and Jet2 that customers were booking later, Sorahan said: 'We're not seeing those kind of trends at all.' Rivals are likely seeing a negative impact from the resolution of Ryanair's dispute with online travel agents, he said. Reuters
The National
15-07-2025
- The National
Measles death triggers warning for parents to check vaccines ahead of travel
Parents are being urged to ensure children are fully vaccinated against measles ahead of any overseas travel this summer as the number of cases continues to climb in Europe and the US. A child in Liverpool, England recently died from the disease, as the UK battles with plummeting vaccination rates. National uptake of the measles, mumps and rubella (MMR) vaccine has dropped to about 84 per cent since 2015 in the UK, well below the recommended level of 95 per cent to ensure adequate herd immunity and protect vulnerable groups. It is a similar trend in the US, where measles cases have climbed to their highest level for 30 years. According to the US Centres for Disease Control and Prevention, there were 1,288 confirmed cases of measles on July 9, including one adult and two infant deaths. The highly infectious disease was eliminated from the US in 2000 but has undergone a resurgence due to rising vaccine hesitancy and misinformation circulating online relating to safety. Meanwhile, in Europe, measles cases have soared to their highest levels since 1997. Outbreaks have been reported this year in popular summer destinations in France, Italy, Spain and Germany. Doctors are urging UAE families to check their vaccination schedules are up to date before overseas travel. Dr Grace Nehme, a consultant in paediatric haematology and oncology medicine at Clemenceau Medical Centre Hospital in Dubai, said while most children have been vaccinated, some parents remain hesitant. 'In Dubai, hesitancy is less than elsewhere but still some patients are refusing despite all the counselling,' she said. 'We do everything possible and they are still refusing to vaccinate but this is not more than maybe 2 per cent-3 per cent of the population. "For parents of children not yet of age to be vaccinated, usually at one year of age, travelling to an endemic area or an area with an outbreak, we can give the vaccine at nine months. 'But for very small children below that age, parents will have to take extra precautions.' Symptoms to spot Typical symptoms include high fever, cough, runny nose and red, watery eyes. Children often also have a rash that starts on the face and spreads down the body, or tiny white spots inside the mouth. 'Young children travelling with parents this summer, who are not vaccinated, should avoid being around any sick children, especially anyone with fever and rash,' said Dr Nehme. 'They should avoid very crowded areas, which is difficult when you're a tourist and you want to visit all the nice places. 'But if you have a small baby, try to avoid peak times when there are a lot of people. Every time a family travels, children can get sick pretty quickly because they're building their immunity. But for the vaccinated kids, you're not that worried.' Europe reported 127,350 cases of measles in 2024, double the number of incidents reported to the World Health Organisation the previous year. Rising cases have also been reported elsewhere in Nigeria, Indonesia, Pakistan, India and Thailand. 'Summer is a great time for families to travel and it's also a good opportunity to make sure children are up to date on their vaccinations,' said Dr Shruthi Punnapu, a specialist paediatrician at Medcare Women & Children Hospital. 'Before heading out, parents are encouraged to check in with their child's doctor or local health clinic to review the vaccination schedule. 'Most clinics can provide guidance quickly and many vaccines can be given on an accelerated schedule if travel is coming up soon. 'If travelling to areas where there have been recent outbreak of measles in parts of Europe or whooping cough in the US, extra precautions may be recommended.' Vaccine catch-up In recent years, some children have fallen behind on routine vaccines. This can happen for many reasons, from changes in schedules or health coverage to delays during the pandemic. 'The good news is that it's never too late to catch up which helps ensure children are ready not just for travel, but also for school and other activities where illnesses can spread more easily,' said Dr Punnapu. 'It's a simple but powerful way to protect their health and keep everyone safer.' Vaccinations are one of humanity's greatest success stories in public health over the past century. Researchers at the Burnet Institute, in collaboration with Gavi the Vaccine Alliance, found emergency vaccinations against measles, cholera, Ebola, meningitis and yellow fever had reduced the number of deaths by almost 60 per cent between 2000 and 2023. That global response also generated more than $32 billion in economic benefits and prevented further outbreaks of disease, the institute's study on global health security found. Research published in the British Medical Journal of Global Health evaluated 210 outbreaks of five infectious diseases – cholera, Ebola, measles, meningitis and yellow fever – in 49 lower-income countries between 2000 and 2023. Experts said the findings highlighted the value of rapid outbreak response times and maintaining strong routine immunisation coverage, especially in high-risk settings to prevent and minimise cases and deaths. When outbreaks have occurred in lower-income countries since 2005, measles vaccinations have reduced cases by 59 per cent and deaths by 52 per cent. Immunisation campaigns also dramatically helped reduce the risk of large outbreaks from spreading further in communities with low baseline immunity due to lower vaccine coverage. Declining protection rates Like most other vaccines, measles immunisation has declined since the Covid-19 pandemic. Gavi has led efforts to bring nations back up to the coverage required to prevent large-scale outbreaks of the disease. Since 2021, about 35 million children have been protected as a result of outbreak response vaccination campaigns. 'For the first time, we are able to comprehensively quantify the benefit, in human and economic terms, of deploying vaccines against outbreaks of some of the deadliest infectious diseases,' said Dr Sania Nishtar, chief executive of Gavi. 'This study demonstrates clearly the power of vaccines as a cost-effective countermeasure to the increasing risk the world faces from outbreaks. 'It also underscores the importance of fully funding Gavi, so it can continue to protect communities in the next five years to come.'
